#
# Copyright (c) 2005 Richard Cameron, CiteULike.org
# Copyright (c) 2008 Graham Triggs
# All rights reserved.
#
# Redistribution and use in source and binary forms, with or without
# modification, are permitted provided that the following conditions
# are met:
# 1. Redistributions of source code must retain the above copyright
#    notice, this list of conditions and the following disclaimer.
# 2. Redistributions in binary form must reproduce the above copyright
#    notice, this list of conditions and the following disclaimer in the
#    documentation and/or other materials provided with the distribution.
# 3. All advertising materials mentioning features or use of this software
#    must display the following acknowledgement:
#        This product includes software developed by
#        CiteULike <http://www.citeulike.org> and its
#        contributors.
# 4. Neither the name of CiteULike nor the names of its
#    contributors may be used to endorse or promote products derived
#    from this software without specific prior written permission.
#
# THIS SOFTWARE IS PROVIDED BY CITEULIKE.ORG AND CONTRIBUTORS
# ``AS IS'' AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED
# TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR
# PURPOSE ARE DISCLAIMED.  IN NO EVENT SHALL THE FOUNDATION OR CONTRIBUTORS
# BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR
# CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF
# SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS
# INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN
# CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE)
# ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE
# POSSIBILITY OF SUCH DAMAGE.
#

# Each plugin needs a description so the driver can advertise the details
# to the users on the site
plugin {
	# Integer version number for the plugin code. When this number is incremented,
	# CiteULike may reparse all existing articles with the new code.
	version {1}

	# The name of the plugin, as displayed on the "CiteULike supports..." page
	name {Open Repository}

	# The link the front page of this service
	url {http://www.openrepository.com}

	# Any additional information which needs to be displayed to the user.
	# E.g. "Experimental support"
	blurb {Experimental support}

	# Your name
	author {Graham Triggs}

	# Your email address
	email {graham@biomedcentral.com}

	# Language you wrote the plugin in
	language {perl}

	# Regular expression to match URLs that the plugin is
	# *potentially* interested in. Any URL matching this regexp
	# will cause your parser to be invoked. Currently, this will
	# require fork()ing a process, so you should try to reduce the number
	# of false positives by making your regexp as restrictive as possible.

	# RDC: build up the second part of this regexp with this one-liner:

	# curl 'http://www.biomedcentral.com/browse/journals/' | grep 'A class=hiddenlink' |grep http | sed 's/..*http:..\(.*\)\/*">/\1/' |sed 's/\/*$//' |sed ':start N; s/\n/|/; b start'

	regexp {^(http://([A-Za-z0-9]+\.openrepository.com/[A-Za-z0-9]+)/handle)|(http://(www.e-space.mmu.ac.uk/e-space|www.hirsla.lsh.is/lsh|arrts.gtcni.org.uk/gtcni|eric.exeter.ac.uk/exeter)/handle)}
}

format_linkout OPNREP {
    return [list "Open Repository"  "http://hdl.handle.net/${ikey_1}/${ikey_2}"]
}

#
# TESTS
#

# Each plugin MUST provide a set of tests. The motivation behind this is
# that web scraping code is inherently fragile, and is likely to break whenever
# the provider decides to redesign their site. CiteULike will periodically
# run tests to see if anything has broken.

# Please provide as comprehensive a set of tests as possible.
# If you ever fix a bug in the parser, it is highly recommended that
# you add the offending page as a test case.
#
test {http://www.hirsla.lsh.is/lsh/handle/2336/15442} {
	formatted_url {DOI http://dx.doi.org/10.1046%2Fj.1365-2133.2003.05318.x}
	formatted_url {{Open Repository} http://hdl.handle.net/2336/15442}
	linkout {DOI {} 10.1046/j.1365-2133.2003.05318.x {} {}}
	linkout {OPNREP 2336 {} 15442 {}}
	type JOUR
	year 2003
	volume 148
	serial 0007-0963
	title {The effects of ultraviolet B treatment on the expression of adhesion molecules by circulating T lymphocytes in psoriasis}
	url {http://hdl.handle.net/2336/15442}
	start_page 996
	end_page 1000
	journal Br
	abstract {BACKGROUND: T lymphocytes are believed to play a role in the pathogenesis of psoriasis; > 80% of T lymphocytes that infiltrate psoriatic lesions express the surface glycoprotein cutaneous lymphocyte-associated antigen (CLA), compared with < 20% in the blood. Exposure to ultraviolet (UV) B is an effective treatment for psoriasis. OBJECTIVES: To compare the effects of UVB treatment of psoriasis on the expression of CLA and several other surface markers expressed by circulating T lymphocytes. METHODS: Peripheral blood mononuclear cells from psoriatic patients were stained for adhesion molecules and stimulated with streptococcal antigens before and once weekly during 3 weeks of UVB treatment. RESULTS: A marked and progressive decrease was observed during the treatment in expression of the CLA and the very late antigen-4alpha by T cells; this decrease correlated closely with clinical improvement (Psoriasis Area and Severity Index). T-cell expression of intercellular adhesion molecule-1 was not significantly affected during the treatment and no change was observed in the activation markers CD25 and CD69 or lymphocyte proliferation after stimulation with streptococcal antigens or superantigens. CONCLUSIONS: UVB treatment is associated with a marked reduction in the expression of skin-homing molecules by circulating T cells. This may be relevant to the therapeutic effect of UVB in psoriasis.}
	author {Sigmundsdottir {} H {Sigmundsdottir, H}}
	author {Gudjonsson {} JE {Gudjonsson, J E}}
	author {Valdimarsson {} H {Valdimarsson, H}}
	plugin openrepository
	status ok
}